News

CMN Weekly (28 October 2022) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Oct. 28, 2022

Top picks

Research

Industry

Detection

Reviews

  • "Advances in CRISPR therapeutics" is a review by American researchers. It takes a historical perspective on the application of CRISPR technology to edit the non-coding genome, modulate gene regulation, make precise genetic changes and target infectious diseases that have the potential to lead to curative therapies for many previously untreatable diseases.

News from CRISPR Medicine News

  • We brought a special update with news from the gene-editing clinical trials on Wednesday. The last few months have seen many updates for gene-editing therapies in development for cancer, HIV, infectious disease and several inherited diseases, and they are all here.

To get more of the CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

News: CMN Weekly (28 October 2022) - Your Weekly CRISPR Medicine News
Search your next CRISPR job here...
Search your next CRISPR job here...
CLINICAL TRIALS
Solid Tumors (NCT03970382)
Sponsors:
PACT Pharma, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Beta-Thalassemia, BT, (NCT05442346)
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine